Additional Advances in Renal Cell Carcinoma Research and Clinical Trials With Nazy Zomorodian, NP, RNC, MSN, CUNP, CCRC episode artwork

EPISODE · Mar 3, 2025 · 10 MIN

Additional Advances in Renal Cell Carcinoma Research and Clinical Trials With Nazy Zomorodian, NP, RNC, MSN, CUNP, CCRC

from Oncology Data Advisor · host i3 Health

As we recognize Kidney Cancer Awareness Month this March, advancements in renal cell carcinoma (RCC) treatment continue to evolve. Recently, Nazy Zomorodian, NP, RNC, MSN, CUNP, CCRC, a Nurse Practitioner and expert in genitourinary oncology, chaired the i3 Health’s NCPD activity titled Toxicity Management and Symptom Control in Advanced RCC: Playbook Update. In this interview, she shares updates in RCC treatment, strategies for toxicity management, and the importance of patient education. Click here for the full NCPD activity! https://i3health.com/course-information/toxicity-management-and-symptom-control-in-advanced-rcc-playbook-update

Episode metadata supplied by the publisher feed · Published Mar 3, 2025

Embed this episode

NOW PLAYING

Additional Advances in Renal Cell Carcinoma Research and Clinical Trials With Nazy Zomorodian, NP, RNC, MSN, CUNP, CCRC

0:00 10:31

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Oncology Data Advisor?

This episode is 10 minutes long.

When was this Oncology Data Advisor episode published?

This episode was published on March 3, 2025.

Can I download this Oncology Data Advisor episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!